Long-read Oxford Nanopore sequencing enables rapid, cost-effective, and comprehensive TTR genetic testing for hereditary transthyretin amyloidosis.
- DOI
- 10.1515/cclm-2026-0553
- Published
- 2026 Aug 24
- Container
- Clinical chemistry and laboratory medicine
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1515/cclm-2026-0553,
title = {Long-read Oxford Nanopore sequencing enables rapid, cost-effective, and comprehensive TTR genetic testing for hereditary transthyretin amyloidosis.},
author = {Millat G and Messaoudi K and Chanavat V and Testard Q and Lucain M and Cazeneuve C and Jedraszak G and Janin A},
year = {2026},
journal = {Clinical chemistry and laboratory medicine},
doi = {10.1515/cclm-2026-0553},
url = {https://doi.org/10.1515/cclm-2026-0553}
}RIS
TY - JOUR TI - Long-read Oxford Nanopore sequencing enables rapid, cost-effective, and comprehensive TTR genetic testing for hereditary transthyretin amyloidosis. AU - Millat G AU - Messaoudi K AU - Chanavat V AU - Testard Q AU - Lucain M AU - Cazeneuve C AU - Jedraszak G AU - Janin A PY - 2026 JO - Clinical chemistry and laboratory medicine DO - 10.1515/cclm-2026-0553 UR - https://doi.org/10.1515/cclm-2026-0553 ER -
APA
G, M., K, M., V, C., Q, T., M, L., C, C., G, J., & A, J. (2026). Long-read Oxford Nanopore sequencing enables rapid, cost-effective, and comprehensive TTR genetic testing for hereditary transthyretin amyloidosis.. Clinical chemistry and laboratory medicine. https://doi.org/10.1515/cclm-2026-0553
Source records
- pubmed · retrieved 2026-09-27T14:38:47.368Z
- europe-pmc · retrieved 2026-09-27T14:38:47.468Z
- hal · retrieved 2026-09-27T14:38:47.506Z